Joaquin J Jimenez

US Patent:

7143601, Dec 5, 2006

Filed:

Apr 30, 2004

Appl. No.:

10/836719

Inventors:

Joaquin Jimenez - Hialeah FL, US

International Classification:

F25D 3/08

US Classification:

624577, 136 16, 22059203

Abstract:

The cooler is a standard piece of recreational equipment. This device combines the utility of a cooler with an umbrella, a radio, speakers, and a bottle opener. Because this device combines all three functions in one device the consumer is not required to purchase or carry each item separately. A handle and wheels have been installed on this device to allow the user an easy way to transport this device.

US Patent:

8105632, Jan 31, 2012

Filed:

Dec 7, 2005

Appl. No.:

11/792399

Inventors:

Wenche Jy - Miami FL, US
Joaquin J. Jimenez - Miami FL, US
Lawrence L. Horstmann - Miami FL, US
Yeon S. Ahn - Miami FL, US
Eugene Ahn - Miami FL, US

Assignee:

University of Miami - Miami FL

International Classification:

A61K 35/18

US Classification:

424533, 424 9373, 424529

Abstract:

Compositions comprising membrane-derived and synthetic microparticles that induce platelet aggregation and are useful for treating bleeding disorders, particularly those involving platelet dysfunction. Microparticles include endothelial derived microparticles (EMP), platelet derived microparticles (PMP), erythrocyte derived microparticles (RMP), and synthetic microparticles (SMP), and are used to treat disorders such as thrombocytopenia caused by chemotherapy.

US Patent:

20020035097, Mar 21, 2002

Filed:

Sep 17, 2001

Appl. No.:

09/955241

Inventors:

Joaquin Jimenez - Miami FL, US
Adel Yunis - Miami FL, US

International Classification:

A61K031/7105
A61K031/59

US Classification:

514/167000, 514/049000

Abstract:

The present invention relates, in general, to a method of inhibiting alopecia, or hair loss, and, in particular, to a method of inhibiting alopecia induced by chemotherapeutic agents. The invention further relates to a composition suitable for use in such a method. Active agents for use in the above method include proteinaceous growth factors, such as EGF, and/or vitamin Dor metabolites thereof.

US Patent:

20100196308, Aug 5, 2010

Filed:

Jan 27, 2010

Appl. No.:

12/695113

Inventors:

Joaquin J. Jimenez - Miami FL, US
John Patrick McCook - Frisco TX, US
Niven Rajin Narain - Cambridge MA, US

International Classification:

A61K 38/19
A61K 38/22
A61P 7/06
A61K 31/593

US Classification:

424 851, 514 8, 514167

Abstract:

The present disclosure relates to the use of vitamin D compounds, such as vitamin D3, or analogs and/or metabolites thereof, to modulate bone marrow progenitors and stromal cells prior to the administration of antineoplastic agents. The methods of the present disclosure may ameliorate myelosuppression by increasing the availability of pluripotent stem cell progenitors, and can be used in combination with standard therapy (e.g. granulocyte stimulating factor) to increase proliferation of myeloid cells and/or improve their mobilization from the bone marrow, thereby diminishing the dose and administration of colony-stimulating factors (CSFs) as well as the recuperation time following chemotherapy.

US Patent:

20110059917, Mar 10, 2011

Filed:

Aug 10, 2010

Appl. No.:

12/853431

Inventors:

Joaquin Jimenez - Miami FL, US
Niven Rajin Narain - Cambridge MA, US
John Patrick McCook - Frisco TX, US

International Classification:

A61K 31/7068
A61K 31/59
A61K 31/65
A61K 31/66
A61P 17/14
A61P 35/00

US Classification:

514 49, 514167, 514154, 514110

Abstract:

The invention provides methods and pharmaceutical compositions for preventing or treating alopecia, such as chemotherapy-induced alopecia (CIA). The pharmaceutical compositions of the invention comprises an effective amount of a vitamin D compound in a formulation that topically delivers the vitamin D compound to the epidermis layer but substantially avoids the dermis layer. In chemotherapy patients, the pharmaceutical compositions of the invention can be administered either before or concurrent with the chemotherapy medication.

US Patent:

20120269867, Oct 25, 2012

Filed:

Apr 4, 2012

Appl. No.:

13/439615

Inventors:

Joaquin J. Jimenez - Miami FL, US
Niven Rajin Narain - Cambridge MA, US
Rangaprasad Sarangarajan - Boylston MA, US
John Patrick McCook - Frisco TX, US

International Classification:

A61K 31/122
A61P 25/00
A61P 27/10
A61P 35/02
A61K 9/14
A61N 5/10
A61P 35/00
A61P 27/16
B82Y 5/00
B82B 1/00

US Classification:

424400, 424 941, 514690, 600 1, 977773, 977906

Abstract:

The invention provides methods and compositions for treatment of a subject with a central nervous system (CNS) tumor comprising administration of Coenzyme Q10 (CoQ10), particularly when the subject exhibits at least one CNS abnormality as a result of the tumor.

US Patent:

54865093, Jan 23, 1996

Filed:

May 27, 1994

Appl. No.:

8/250646

Inventors:

Joaquin J. Jimenez - Miami FL
Adel A. Yunis - Miami FL

Assignee:

University of Miami - Miami FL

International Classification:

A61K 3159
C07C40100

US Classification:

514167

Abstract:

The present invention relates, in general, to a method of inhibiting alopecia, or hair loss, and, in particular, to a method of inhibiting alopecia induced by chemotherapeutic agents. The invention further relates to a composition suitable for use in such a method. Active agents for use in the above method include proteinaceous growth factors, such as EGF, and/or vitamin D. sub. 3 or metabolites thereof.

US Patent:

58885510, Mar 30, 1999

Filed:

Dec 11, 1995

Appl. No.:

8/570411

Inventors:

Joaquin Jimenez - Miami FL
Adel A. Yunis - Boca Raton FL

Assignee:

University of Miami - Miami FL

International Classification:

A61K 3514

US Classification:

424534

Abstract:

The present invention relates to compositions useful in the stimulation of hair growth. These compositions comprise a conditioned medium obtained from a cell culture of human mononuclear cells or a conditioned or extracted medium obtained from a cell culture of mammalian normal or transformed cells or cancer cells.